[{"AccountsPayableCurrent_0_Q1_USD":9966000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":4583000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":202848000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":289441000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":290977000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":1750000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":214000.0,"AssetsFairValueDisclosure_0_Q1_USD":356460000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":2551000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-138000.0,"ConvertibleDebtFairValueDisclosures_0_Q1_USD":195600000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":-4887000.0,"MarketableSecurities_0_Q1_USD":289441000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":13312000.0,"CostMethodInvestments_0_Q1_USD":15000000.0,"LiabilitiesFairValueDisclosure_0_Q1_USD":66600000.0,"ConvertibleDebtNoncurrent_0_Q1_USD":207412000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":5910000.0,"OtherLiabilitiesCurrent_0_Q1_USD":8435000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-7666000.0,"InterestIncomeExpenseNet_1_Q1_USD":1976000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":67019000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":86593000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1_Q1_USD":49153000.0,"AccruedSalariesCurrent_0_Q1_USD":7830000.0,"InventoryValuationReserves_0_Q1_USD":3200000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":3508000.0,"EarningsPerShareDiluted_1_Q1_USD":0.02,"ProceedsFromStockOptionsExercised_1_Q1_USD":60000.0,"StockGrantedDuringPeriodValueSharebasedCompensationGross_1_Q1_USD":60000.0,"DebtInstrumentRepurchaseAmount_0_Q1_USD":23400000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q1_USD":0.0,"DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0_Q1_USD":290977000.0,"SaleOfStockNumberOfSharesIssuedInTransaction_1_Q1_shares":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":47769000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":4988000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_1_Q1_USD":5308000.0,"OtherNoncashIncomeExpense_1_Q1_USD":25000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-2417000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-2417000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":0.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":0.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":2458000.0,"OperatingLeaseLiability_0_Q1_USD":2458000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":100000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":1936000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":622000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":2558000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":3085000.0,"IncomeTaxReceivable_0_Q1_USD":20183000.0,"ForeignCurrencyTransactionGainLossRealized_1_Q1_USD":191000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-40000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":1750000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":208257000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q1_USD":1750000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q1_USD":208257000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q1_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q1_USD":0.0,"IncreaseDecreaseInIncomeTaxesReceivable_1_Q1_USD":18788000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":5656000.0,"OperatingLeaseExpense_1_Q1_USD":400000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-1418000.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"AccruedLiabilitiesCurrent_0_Q1_USD":41590000.0,"StockholdersEquity_0_Q1_USD":225748000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-415636000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2617000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":5309000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":208000.0,"NetIncomeLoss_1_Q1_USD":808000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-29155000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":39551000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-5773000.0,"LiabilitiesCurrent_0_Q1_USD":68091000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":573063000.0,"Liabilities_0_Q1_USD":347315000.0,"InventoryNet_0_Q1_USD":6593000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":61000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-18976000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-18168000.0,"CostsAndExpenses_1_Q1_USD":1370000.0,"CommonStockValue_0_Q1_USD":4000.0,"CommonStockSharesOutstanding_0_Q1_shares":43153215.0,"CommonStockSharesIssued_0_Q1_shares":43153215.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":67019000.0,"AssetsCurrent_0_Q1_USD":406630000.0,"Assets_0_Q1_USD":573063000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":14807564000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-1500000.0,"AccountsReceivableNetCurrent_0_Q1_USD":18085000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":93706000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":196000.0,"OperatingExpenses_1_Q1_USD":62836000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"ProvisionForDoubtfulAccounts_1_Q1_USD":0.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":4406000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":642880000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":43122897.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":5714000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":19.11,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":5200000.0,"OtherAssetsNoncurrent_0_Q1_USD":6803000.0,"NonoperatingIncomeExpense_1_Q1_USD":-3101000.0,"ImpairmentOfIntangibleAssetsFinitelived_1_Q1_USD":0.0,"Goodwill_0_Q1_USD":936000.0,"EarningsPerShareBasic_1_Q1_USD":0.02,"BusinessCombinationContingentConsiderationLiability_0_Q1_USD":66600000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":-6971000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-190000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":156077000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":249783000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-7519000.0,"IncreaseDecreaseInInventories_1_Q1_USD":958000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-16577000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":5174000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":43592499.0,"ShareBasedCompensation_1_Q1_USD":5910000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":33139000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":30249000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":20000000.0,"OperatingIncomeLoss_1_Q1_USD":-15067000.0,"TemporaryEquityForeignCurrencyTranslationAdjustments_1_Q1_USD":191000.0,"Ticker":"TVTX","CIK":"1438533","name":"RETROPHIN, INC.","OfficialName":"Travere Therapeutics Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1905907401.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200511"}]